Although there are several open gaps in Pfizer's chart, I'd like to highlight two of them, as well as the two-times crossed downtrend-line.
Personally I see this as a strong signal that should push the chart even further.
As a logical next step I'd expect the stock to close at least one of the open gaps on the downside and then to rise and close the July '19 gap at USD 41,44.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。